Search results for: 'vaccine 2022 2022 deal trends players and financials'
- Did you mean
- vaccine 2025 2025 deal trends players and financials
- Related search terms
- vaccine 2024 2024 deal trends players and financials
- vaccine 2016 2024 deal trends players and financials
- vaccine 2020 2022 deal trend players and financial
- vaccine 2024 2016 deal trends players and financial
- vaccine 2010 2016 deal trends players and financing
-
Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Respiratory Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Respiratory Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2025
Learn More -
Infectious Diseases Collaboration and Licensing Deals 2019-2025April 2025$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2025February 2025$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2025
Learn More
